CF33 and OnCARlytics trials are progressing as planned as far as...

  1. 366 Posts.
    lightbulb Created with Sketch. 275
    CF33 and OnCARlytics trials are progressing as planned as far as I can see.

    I think you have your trials mixed up. Cohort A is in the Azer-cel trial. Cohort B in Azer-cel has IL-2 added. Cohort B continues to enrol as it showed the best results. That is what a phase 1 is designed to do, decide the optimal dose and combinations to take forward.





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $80.77M
Open High Low Value Volume
28.0¢ 28.0¢ 27.0¢ $461.4K 1.681M

Buyers (Bids)

No. Vol. Price($)
1 10000 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 134437 7
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.